Atso Raasmaja

2.0k total citations
63 papers, 1.7k citations indexed

About

Atso Raasmaja is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Atso Raasmaja has authored 63 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 20 papers in Physiology and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Atso Raasmaja's work include Adipose Tissue and Metabolism (17 papers), Virus-based gene therapy research (10 papers) and RNA Interference and Gene Delivery (10 papers). Atso Raasmaja is often cited by papers focused on Adipose Tissue and Metabolism (17 papers), Virus-based gene therapy research (10 papers) and RNA Interference and Gene Delivery (10 papers). Atso Raasmaja collaborates with scholars based in Finland, United States and Sweden. Atso Raasmaja's co-authors include Pekka T. Männistö, Amalia Rubio, Pasi Lampela, R. Hiltunen, P. Reed Larsen, Jan Nedergaard, Katja A. Puttonen, Raimo K. Tuominen, Märt Saarma and Susanne Bäck and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Biochemical Journal.

In The Last Decade

Atso Raasmaja

63 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atso Raasmaja Finland 26 643 458 442 189 184 63 1.7k
Janneth González Colombia 26 882 1.4× 421 0.9× 458 1.0× 323 1.7× 125 0.7× 75 2.2k
Hiroaki Okuda Japan 27 1.1k 1.6× 409 0.9× 414 0.9× 62 0.3× 176 1.0× 113 2.8k
Yoshihisa Ito Japan 27 805 1.3× 470 1.0× 592 1.3× 243 1.3× 55 0.3× 107 2.4k
Joon Ha Park South Korea 28 845 1.3× 682 1.5× 492 1.1× 134 0.7× 64 0.3× 204 3.1k
Marco Ávila-Rodriguez Colombia 27 640 1.0× 245 0.5× 483 1.1× 222 1.2× 142 0.8× 60 1.8k
Yam Nath Paudel Malaysia 27 793 1.2× 468 1.0× 397 0.9× 300 1.6× 80 0.4× 60 2.3k
Kyoung‐Shim Kim South Korea 27 816 1.3× 583 1.3× 351 0.8× 199 1.1× 100 0.5× 73 2.2k
Igor Rebrin United States 26 1.4k 2.1× 251 0.5× 549 1.2× 97 0.5× 117 0.6× 44 2.3k
Amandine Grimm Switzerland 25 1.1k 1.8× 403 0.9× 1000 2.3× 141 0.7× 152 0.8× 49 2.3k
José M. Medina Spain 24 852 1.3× 461 1.0× 500 1.1× 102 0.5× 74 0.4× 55 2.0k

Countries citing papers authored by Atso Raasmaja

Since Specialization
Citations

This map shows the geographic impact of Atso Raasmaja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atso Raasmaja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atso Raasmaja more than expected).

Fields of papers citing papers by Atso Raasmaja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atso Raasmaja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atso Raasmaja. The network helps show where Atso Raasmaja may publish in the future.

Co-authorship network of co-authors of Atso Raasmaja

This figure shows the co-authorship network connecting the top 25 collaborators of Atso Raasmaja. A scholar is included among the top collaborators of Atso Raasmaja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atso Raasmaja. Atso Raasmaja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bäckström, Pia, et al.. (2019). The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats. European Neuropsychopharmacology. 29(12). 1386–1396. 7 indexed citations
2.
Bäckström, Pia, et al.. (2018). Amphetamine primes enhanced motivation toward uncertain choices in rats with genetic alcohol preference. Psychopharmacology. 235(5). 1361–1370. 2 indexed citations
3.
Raasmaja, Atso, et al.. (2016). Accumbal mu-Opioid Receptors Modulate Ethanol Intake in Alcohol-Preferring Alko Alcohol Rats. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 2 indexed citations
4.
Myöhänen, Timo T., et al.. (2013). Catechol-O-Methyltransferase (COMT) Protein Expression and Activity after Dopaminergic and Noradrenergic Lesions of the Rat Brain. PLoS ONE. 8(4). e61392–e61392. 15 indexed citations
5.
Ossola, Bernardino, et al.. (2011). Minocycline protects SH‐SY5Y cells from 6‐hydroxydopamine by inhibiting both caspase‐dependent and ‐independent programmed cell death. Journal of Neuroscience Research. 90(3). 682–690. 21 indexed citations
6.
Voutilainen, Merja H., Susanne Bäck, Johan Peränen, et al.. (2010). Chronic infusion of CDNF prevents 6-OHDA-induced deficits in a rat model of Parkinson's disease. Experimental Neurology. 228(1). 99–108. 110 indexed citations
7.
Lehtonen, Šárka, Pekka T. Männistö, & Atso Raasmaja. (2008). Expression of tyrosine hydroxylase in the striatum of atipamezole-treated rats. European Journal of Pharmaceutical Sciences. 36(4-5). 602–604. 1 indexed citations
8.
Ossola, Bernardino, Tiina M. Kääriäinen, Atso Raasmaja, & Pekka T. Männistö. (2008). Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. Toxicology. 250(1). 1–8. 38 indexed citations
9.
Puttonen, Katja A., Šárka Lehtonen, Pasi Lampela, Pekka T. Männistö, & Atso Raasmaja. (2007). Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines. Toxicology in Vitro. 22(1). 182–189. 24 indexed citations
10.
Raasmaja, Atso & David A. York. (2006). Pharmacological characterization of α1- and β-adrenergic synergism of 5′DII activity in rat brown adipocytes. Archives of Physiology and Biochemistry. 112(1). 23–30. 2 indexed citations
11.
Puttonen, Katja A., Šárka Lehtonen, Atso Raasmaja, & Pekka T. Männistö. (2006). A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine. Toxicology in Vitro. 20(8). 1446–1454. 32 indexed citations
12.
Puttonen, Katja A., et al.. (2003). Increased p53 levels without caspase-3 activity and change of cell viability in 6-hydroxydopamine-treated CV1-P cells. Cell Biology and Toxicology. 19(3). 177–187. 8 indexed citations
13.
Lampela, Pasi, Matti Elomaa, Marika Ruponen, et al.. (2003). Different synergistic roles of small polyethylenimine and Dosper in gene delivery. Journal of Controlled Release. 88(1). 173–183. 42 indexed citations
14.
Wurster, Siegfried, et al.. (2003). Identification and Characterization of the Imidazoline I2b-binding Sites in the Hamster Brown Adipose Tissue as a Study Model for Imidazoline Receptors. Archives of Physiology and Biochemistry. 111(2). 159–166. 3 indexed citations
15.
Lampela, Pasi, Marko Huotari, Mart Ustav, et al.. (2003). Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures. Plasmid. 50(3). 230–235. 4 indexed citations
16.
Lampela, Pasi, et al.. (2002). The use of low‐molecular‐weight PEIs as gene carriers in the monkey fibroblastoma and rabbit smooth muscle cell cultures. The Journal of Gene Medicine. 4(2). 205–214. 31 indexed citations
17.
Huotari, Marko, Joseph A. Gogos, Maria Karayiorgou, et al.. (2002). Brain catecholamine metabolism in catechol‐O‐methyltransferase (COMT)‐deficient mice. European Journal of Neuroscience. 15(2). 246–256. 152 indexed citations
18.
Lampela, Pasi, Ene Ustav, Mart Ustav, et al.. (2001). Efficient Transfection of Novel Bovine Papillomavirus 1 Expression Plasmids. Plasmid. 46(3). 163–169. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026